4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001140361-22-006594
Options or other derivatives
- Chief Financial Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kolean Chad J Chief Financial Officer | 2022-02-22 | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/form4.xml…